Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Denmark produces PET (positron emission tomography) scanning report:

This article was originally published in Clinica

Executive Summary

Denmark's Centre for Evaluation and Health Technology Assessment (MTV-Instituttet) has published a report on the use of PET scanning. Special focus has been placed on the use of the agent F-18-fluorodeoxyglucose (FDG) in cancer diagnostics. The use of FDG is currently covered by two Danish laws on medical products and radioactive substances. The report also highlights the effectiveness of PET scanning in reducing the number of deaths as well as helping to avoid unnecessary surgery.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT071570

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel